» Articles » PMID: 14654779

Identification of Novel ERK-mediated Feedback Phosphorylation Sites at the C-terminus of B-Raf

Overview
Journal Oncogene
Date 2003 Dec 5
PMID 14654779
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

The extracellular signal-regulated kinase (ERK) pathway plays an important role during the development and activation of B lymphocytes. We have recently shown that B-Raf is a dominant ERK activator in B-cell antigen receptor signalling. We now show that B-Raf is hyperphosphorylated upon BCR engagement and undergoes a prominent electrophoretic mobility shift. This shift correlates with ERK activation and is prevented by the MEK inhibitor U0126. Syk-deficient DT40 B cells display neither dual ERK phosphorylation nor a mobility shift of B-Raf upon BCR engagement. The inducible expression of a constitutively active B-Raf in this mutant line restores dual ERK phosphorylation and the mobility shift of endogenous B-Raf, indicating that these two events are connected to each other. By site-directed mutagenesis studies, we demonstrate that the shift is due to an ERK2-mediated feedback phosphorylation of serine/threonine residues within an evolutionary conserved SPKTP motif at the C-terminus of B-Raf. Replacement of these residues by negatively charged amino acids causes a constitutive mobility shift and a reduction of PC12 cell differentiation. We discuss a model in which ERK-mediated phosphorylation of the SPKTP motif is involved in negative feedback regulation of B-Raf.

Citing Articles

The Raf/LIN-45 C-terminal distal tail segment negatively regulates signaling in Caenorhabditis elegans.

Townley R, Stacy K, Cheraghi F, de la Cova C Genetics. 2024; 228(3).

PMID: 39288021 PMC: 11538406. DOI: 10.1093/genetics/iyae152.


The mTOR pathway controls phosphorylation of BRAF at T401.

Christen D, Lauinger M, Brunner M, Dengjel J, Brummer T Cell Commun Signal. 2024; 22(1):428.

PMID: 39223665 PMC: 11370054. DOI: 10.1186/s12964-024-01808-2.


Regulation of RAF family kinases: new insights from recent structural and biochemical studies.

Spencer-Smith R, Morrison D Biochem Soc Trans. 2024; 52(3):1061-1069.

PMID: 38695730 PMC: 11346419. DOI: 10.1042/BST20230552.


Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells.

Al Hmada Y, Brodell R, Kharouf N, Flanagan T, Alamodi A, Hassan S Cancers (Basel). 2024; 16(2).

PMID: 38275910 PMC: 10814963. DOI: 10.3390/cancers16020470.


Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.

Bahar M, Kim H, Kim D Signal Transduct Target Ther. 2023; 8(1):455.

PMID: 38105263 PMC: 10725898. DOI: 10.1038/s41392-023-01705-z.